Labcorp Holdings Inc. (NYSE: LH) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $30.2B. The Maz Rating grades it against the other companies in its sector.
Labcorp Holdings Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $372.46, Labcorp Holdings Inc. trades at 30.4x trailing earnings, 2.1x sales and 3.4x book value, with an EV/EBITDA of 17.0. Over the last twelve months it generated about $14.6B of revenue and $996M of net income. It runs a gross margin of 29.0%, an operating margin of 10.3% and a net margin of 6.9%. It shows return on equity of 11.5%, return on invested capital of 7.3% and a free cash flow yield of 4.3%. On the balance sheet: a debt-to-equity ratio of 0.77 and a current ratio of 1.41. Over the past 52 weeks the share price ranged from $245.00 to $375.10, with a beta of 0.84.
Labcorp Holdings Inc. pays a dividend yielding 0.77%, with 24% of earnings paid out. Its Maz Dividend Score is 1.97 out of 5, ranked against the other dividend payers in its sector (Safety 3.17, Growth 2.70, Yield 2.57, Consistency 1.64).
35 Wall Street analyst ratings cover the stock: 26 Buy and 9 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, Labcorp Holdings Inc. (LH) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 21.7% / 30% · (Cash+Inv) / Mkt Cap (36m) 1.45% / 30% · Interest income / Revenue 0.04% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 21.7% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 0.97% / 33% · Receivables / Mkt Cap (36m) 9.48% / 49% · Interest income / Revenue 0.04% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 21.7% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 0.97% / 33.33% · Receivables / Mkt Cap (24m) 9.48% / 33.33% · Interest income / Revenue 0.04% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 31.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 2.56% / 33.33% · Receivables / Avg Assets (4Q) 13.0% / 33.33% · Interest income / Revenue 0.04% / 5% | Pass |
| FTSE | Debt / Total Assets 30.9% / 33.33% · (Cash+ST Inv) / Total Assets 1.38% / 33.33% · (Cash+Recv) / Total Assets 14.9% / 33.33% · Interest income / Revenue 0.04% / 5% | Pass |
Yes. As of September 2026, Labcorp Holdings Inc. (LH) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Labcorp Holdings Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.04% of each dividend: Labcorp Holdings Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.